Drugs News and Research

RSS

Risk of opioid overdose rises after de-addiction treatment completion

A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, “Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder”, and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.

2 Dec 2019

SDSU researchers show cancer-inhibiting potential of flavonoid metabolite

Eating fruits and vegetables is more important than ever.

2 Dec 2019

New treatment could make passing kidney stones faster and less painful

Every year, more than half a million Americans visit the emergency room for kidney stone problems. In most cases, the stones eventually pass out of the body on their own, but the process can be excruciatingly painful.

2 Dec 2019

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

2 Dec 2019

Scientists discover new principle for activation of cancer genes

Researchers have long known that some genes can cause cancer when overactive, but exactly what happens inside the cell nucleus when the cancer grows has so far remained enigmatic.

2 Dec 2019

Experimental therapies offer patients a greater chance of surviving Ebola virus disease

The investigational therapeutics mAb114 and REGN-EB3 offer patients a greater chance of surviving Ebola virus disease compared to the investigational treatment ZMapp, according to published results from a clinical trial conducted in the Democratic Republic of the Congo.

2 Dec 2019

New medicine could reduce number of infants dying from AIDS

A new, strawberry-flavored, granule-form medicine may be a solution for treating infants with AIDs.

2 Dec 2019

New medicine could reduce number of infant deaths from AIDS

A new, strawberry-flavored, granule-form medicine may be a solution for treating infants with AIDs.

2 Dec 2019

Trial comparing three drugs for status epilepticus

Status epilepticus is a condition that is characterized by repeated seizures and is a medical emergency. Treatment is usually with a Benzodiazepine such as Diazepam or Lorazepam etc. There have been not any studies that look at the comparative benefit of drugs that could be prescribed for those who do not respond to the benzodiazepines. The study titled, “Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus,” was published in the latest issue of the journal New England Journal of Medicine.

1 Dec 2019

New automated method helps identify cancer cell metabolism inhibitors

UCLA Jonsson Comprehensive Cancer Center researchers have developed a new automated method for testing hundreds of molecules at a time to find out which ones block cancer cells from consuming glucose - the sugars they need to spread and grow.

29 Nov 2019

Number of children requiring treatment for cannabis misuse failed to improve in the last 3 years

Public Health England has today revealed that a staggering 12,702 young people entered treatment last year because of problems with cannabis.

29 Nov 2019

Initiatives led by pharmacists can contribute to the prevention of cardiovascular disease

With their expertise in the safe and effective use of medications, pharmacists can help in the management of chronic diseases. A review and analysis published in the British Journal of Clinical Pharmacology indicates that initiatives--such as patient education, medication review, and physical assessments--led by pharmacists can make important contributions to the prevention of cardiovascular disease.

28 Nov 2019

ICR scientists carry out first comprehensive assessment of chemical probe resources

A new report urges biomedical researchers to use online web resources very carefully, taking into account their complementary benefits and weaknesses, when selecting small-molecule chemical probes to help answer their research questions.

28 Nov 2019

NIH Statement for World AIDS Day outlines efforts to end the HIV epidemic

With World AIDS Day on 1st December, we are reminded by the NIH of the work that needs to be done to end the HIV Epidemic.

28 Nov 2019

Pharmacist-led interventions can be pivotal in preventing cardiovascular disease

Pharmacists based in GP practices can play an integral role in the prevention of cardiovascular disease, finds new research led by the University of Birmingham.

28 Nov 2019

Gene discovery in fruit flies could provide clues to counteract mitochondrial diseases

Scientists have identified a protein in fruit flies that can be targeted to reverse the effects of disease-causing mutations in mitochondrial genes. The discovery could provide clues about how to counteract human mitochondrial diseases, for which there is currently no cure.

28 Nov 2019

Comparative study finds three anti-seizure drugs to be equally safe and effective

A new study finds that the three most common treatment options administered in the emergency department for patients who experience refractory status epilepticus are equally safe and effective.

27 Nov 2019

UCLA scientists discover link between a protein and human blood stem cell self-renewal

UCLA scientists have discovered a link between a protein and the ability of human blood stem cells to self-renew. In a study published today in the journal Nature, the team reports that activating the protein causes blood stem cells to self-renew at least twelvefold in laboratory conditions.

27 Nov 2019

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown.

27 Nov 2019

Popular heartburn drug voluntarily recalled for carcinogen levels above FDA standards

The popular heartburn drug ranitidine, commonly known as Zantac, was voluntarily recalled due to the contamination of a human carcinogen that could potentially cause cancer. The recall includes oral tablets, capsules, and syrup.

27 Nov 2019

Drugs News and Research

Risk of opioid overdose rises after de-addiction treatment completion

SDSU researchers show cancer-inhibiting potential of flavonoid metabolite

New treatment could make passing kidney stones faster and less painful

Consortium launches ambitious project to transform the treatment of pain

Scientists discover new principle for activation of cancer genes

Experimental therapies offer patients a greater chance of surviving Ebola virus disease

New medicine could reduce number of infants dying from AIDS

New medicine could reduce number of infant deaths from AIDS

Trial comparing three drugs for status epilepticus

New automated method helps identify cancer cell metabolism inhibitors

Number of children requiring treatment for cannabis misuse failed to improve in the last 3 years

Initiatives led by pharmacists can contribute to the prevention of cardiovascular disease

ICR scientists carry out first comprehensive assessment of chemical probe resources

NIH Statement for World AIDS Day outlines efforts to end the HIV epidemic

Pharmacist-led interventions can be pivotal in preventing cardiovascular disease

Gene discovery in fruit flies could provide clues to counteract mitochondrial diseases

Comparative study finds three anti-seizure drugs to be equally safe and effective

UCLA scientists discover link between a protein and human blood stem cell self-renewal

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Popular heartburn drug voluntarily recalled for carcinogen levels above FDA standards

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News